Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4641]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 2: GU Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
30 Jan 2023
10 fundamental health literacy principles for the public to understand when...
Dr Bishal Gyawali - Queen's University, Kingston, Canada
10 fundamental health literacy principles for the public to understand when reading health-related articles ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Jan 2023
The placebo effect in oncology trials and the criteria for approving drugs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The placebo effect in oncology trials and the criteria for approving drugs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Jan 2023
Elacestrant shows improved PFS in ER-positive/HER2-negative mBC
Dr Virginia Kaklamani - UT Health San Antonio MD Anderson Cancer Center, San...
Elacestrant shows improved PFS in ER-positive/HER2-negative mBC ( Dr Virginia Kaklamani - UT Health San Antonio MD Anderson Cancer Center, San Antonio, USA )
13 Jan 2023
ZUMA-7: Axi-cel is superior to standard of care across common prognostic...
Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
ZUMA-7: Axi-cel is superior to standard of care across common prognostic subgroups in R/R LBCL ( Dr Fred Locke - Moffitt Cancer Center, Tampa, USA )
23 Dec 2022
ASH 2022: Multiple myeloma roundup
Dr Thomas Martin - UCSF Medical Centre, San Francisco, USA
ASH 2022: Multiple myeloma roundup ( Dr Thomas Martin - UCSF Medical Centre, San Francisco, USA )
22 Dec 2022
Breast cancer patients who interrupted endocrine therapy to pursue pregnancy...
Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain
Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )
22 Dec 2022
Interruption of endocrine therapy in young breast cancer patients does not...
Dr Ann Partridge - Dana-Farber Cancer Institute, Boston, USA
Interruption of endocrine therapy in young breast cancer patients does not increase the risk of short-term relapse ( Dr Ann Partridge - Dana-Farber Cancer Institute, Boston, USA )
21 Dec 2022
Genetic profiling identifies patients who can omit radiation therapy after...
Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )
21 Dec 2022
PTCy/Tac/MMF gives a higher 1-year GVHD/relapse or progression-free survival...
Dr Monzr Al Malki - City of Hope, Duarte, USA
PTCy/Tac/MMF gives a higher 1-year GVHD/relapse or progression-free survival compared to Tac/MTX in graft-versus-host disease  ( Dr Monzr Al Malki - City of Hope, Duarte, USA )
21 Dec 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation